What unique physiological benefits does Oxymetholone offer that single-pathway oral androgens cannot match?

Oxymetholone delivers benefits through two converging mechanisms simultaneously: androgen receptor-mediated nitrogen retention and a direct erythropoietic stimulus that elevates red-cell mass. This dual-axis effect means users gain both intramuscular volumisation and enhanced oxygen-carrying capacity within the same cycle window — an advantage that single-pathway oral androgens such as Oxandrolone or Stanozolol cannot replicate at any dose.

Why do experienced athletes consistently choose Oxymetholone over other oral anabolic compounds for rapid strength gains?

Experienced athletes select Oxymetholone because its onset of measurable volumisation and strength improvement is faster than most alternative oral androgens — typically apparent within seven to ten days of starting administration. The compound's combined erythropoietic and anabolic signalling creates a compounded performance benefit that narrower compounds achieve only partially, making it the reference choice when rapid and broad physiological response is the protocol objective.

What makes the benefits of Oxymetholone distinct from those of structurally similar DHT-derived oral steroids?

Although Oxymetholone belongs to the DHT-derived structural class, it produces an erythropoietic drive that other DHT-derived compounds — Masteron or Stanozolol, for example — do not generate. This makes its benefit profile categorically broader: users gain not only androgenic anabolic signalling but also meaningful red-cell mass expansion, a physiological advantage with direct implications for training endurance and recovery speed.

Is the 50mg tablet concentration the highest available in this Oxymetholone product group, and why does concentration matter for dosing accuracy?

Yes — 50 mg per tablet is the highest single-tablet concentration in this product group. Higher concentration per unit means a complete reference daily dose is delivered as a single analytically verified tablet, eliminating the API distribution inconsistencies introduced when lower-dose tablets are split. Each tablet's potency is confirmed by HPLC before batch release, so the 50 mg figure reflects an analytically established quantity, not a nominal label claim.

How does the 100-tablet pack format support structured Oxymetholone protocols without requiring mid-cycle restocking?

The 100-tablet pack provides enough supply depth to cover multi-phase protocols — including an induction period, a full-dose active phase, and a controlled exit window — without interruption. For users following structured cycle architecture, having a single pack that supports the entire planned duration removes the logistical risk of a supply gap mid-cycle, which could disrupt the intended androgenic stimulus profile. (2) angle_used

Advanced Formula

Swiss Pharma

Oxymetholone 50mg/tab 100 Tabletten by Swiss Pharma

Name: Oxymetholone 50mg/tab 100 Tablets by Swiss Pharma
Brand: Swiss Pharma
SKU: ORA-OXYM-SWI-023
Price: 70.00 EUR
Availability: InStock

Swiss Pharma Oxymetholone 50mg/tab is a high-concentration oral androgen delivering one of the broadest physiological benefit profiles in its compound class — each 100-tablet pack formulated at the highest single-tablet concentration available, purpose-built for athletes who require measurable strength and volumising output without any fractional dosing compromise. The compound's distinguishing characteristic is its simultaneous engagement of two independent anabolic axes: androgen receptor-driven nitrogen retention and a direct erythropoietic stimulus that expands red-cell mass within the same administration window. Swiss Pharma enforces a two-stage analytical release gate — per-tablet API content confirmed by HPLC chromatography, then LAL endotoxin clearance on the raw active ingredient — before any batch proceeds to distribution.

€70.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Dual-mechanism action: androgen receptor nitrogen retention combined with erythropoietic red-cell expansion in a single oral compound.
Fastest measurable volumisation onset in its compound class — detectable intramuscular fullness within the first ten days.
50 mg per tablet — the highest single-unit concentration in this product group — delivers a complete reference dose without tablet splitting.
HPLC-verified potency per tablet confirmed at batch level before any pack enters distribution.
LAL endotoxin assay on raw API performed upstream of compression, establishing material integrity at the source.
100-tablet pack depth supports complete structured multi-phase protocols without mid-cycle restocking.
Broader physiological benefit profile than narrower DHT-derived oral androgens, adding erythropoietic advantage to androgenic anabolic signalling.

Phase	dosage	Note
Assessment Phase (Week 1–2)	25–50 mg/day	Establish individual benefit-to-tolerance ratio; baseline ALT/AST and haematocrit recorded before day one.
Active Benefit Phase (Week 3–4)	50 mg/day	Full reference dose aligned with the compound's peak erythropoietic and nitrogen-retention advantage window.
Exit and Transition (Week 5, if applicable)	25 mg/day	Step-down preserves accumulated volumisation benefits while reducing hepatic enzyme trajectory ahead of cessation.

Key takeaways

Recognise Oxymetholone's dual nitrogen-retention and erythropoietic advantages as mechanistically distinct.
Choose the 50mg tablet for analytically verified full-dose precision without splitting.
Expect measurable volumisation onset within the first ten days of administration.
Confirm HPLC and LAL batch documentation before beginning any cycle.
Plan supply depth using the 100-tablet format to avoid mid-protocol gaps.

What Sets Oxymetholone Apart as a Performance Compound

Swiss Pharma Oxymetholone 50mg/tab is a high-concentration oral androgen whose distinguishing characteristic is the breadth of its simultaneous physiological advantages — no other single oral compound in this class delivers volumisation, nitrogen retention, and red-cell mass expansion through converging mechanisms at the same time. Compared to Oxandrolone, Oxymetholone produces a far more pronounced volumising and erythropoietic response per cycle week, a difference measurable in haematocrit elevation within the first fourteen days of administration. Swiss Pharma subjects each production batch to HPLC-based per-tablet potency confirmation, ensuring that the declared 50 mg per unit is analytically verified rather than assumed from batch averages.

The Core Benefits That Define the Compound's Unique Position

Oxymetholone drives nitrogen retention through androgen receptor-mediated transcriptional activity, a mechanism that directly supports lean tissue accrual during caloric surplus. Red-cell mass expansion is an additional — and mechanistically distinct — advantage: Oxymetholone stimulates erythropoiesis, elevating oxygen-carrying capacity in a way that most oral androgens do not achieve at any dose. Together, these two axes make the compound uniquely suited to protocols where both intramuscular volumisation and enhanced training recovery are priority outcomes. Athletes who have used narrower oral androgens report that the onset of scale-weight and intramuscular fullness with Oxymetholone is faster and more pronounced, typically apparent within the first seven to ten days.

Why the 50mg Tablet Concentration Is a Practical Advantage

At 50 mg per tablet — the highest concentration in this product group — each unit represents a full reference daily dose without requiring multiple tablets or splitting. This concentration eliminates the dosing imprecision introduced when lower-strength tablets are divided, preserving the analytical uniformity of each administered dose. The 100-tablet pack provides supply depth that supports structured multi-phase protocols without mid-cycle restocking. Swiss Pharma's LAL endotoxin assay on incoming API confirms raw material integrity before it enters the granulation and compression process, so the quality standard is established at the input stage rather than inferred from finished-product sampling alone.

Usage

Review baseline bloodwork — ALT, AST, haematocrit, and fasting glucose — before taking the first tablet to establish a clear reference point for monitoring the compound's benefit profile.
Begin at the lower end of the assessed dose range to identify your individual response to the compound's dual erythropoietic and nitrogen-retention mechanisms before committing to full-dose exposure.
Administer the tablet with a moderate-sized meal to support gastrointestinal tolerance; avoid very high-fat meals that may delay gastric emptying and shift the absorption window unpredictably.
Maintain consistent daily administration timing to preserve stable androgenic signalling — irregular scheduling reduces the reliability of the compound's nitrogen-retention advantage.
Repeat the ALT, AST, and haematocrit panel at the two-week mark; use the results to confirm whether the planned dose remains appropriate for continued full-phase benefit.
Plan the complete cycle duration before opening the pack; the 100-tablet supply supports a structured multi-phase protocol — map induction, peak-benefit, and exit phases in advance to maximise the compound's unique dual-axis advantage.

Warnings

Contraindications: Oxymetholone 50mg is contraindicated in individuals with pre-existing hepatic impairment, carcinoma of the prostate or breast in male patients, hypercalcaemia, nephrotic syndrome, and in women who are pregnant or may become pregnant. Individuals with known hypersensitivity to any tablet excipient should not use this product.

Side_Effects: Hepatotoxicity is the primary dose- and duration-dependent risk associated with 17α-alkylated oral androgens; ALT and AST elevation is expected and must be monitored. Haematocrit rise secondary to erythropoietic stimulation increases blood viscosity and cardiovascular workload. Additional reported effects include endogenous testosterone suppression, fluid retention, lipid profile shifts (HDL reduction), and, in women, signs of virilisation.

Monitoring: Liver enzyme panels (ALT, AST, ALP) should be assessed at baseline, at the two-week mark, and at cycle conclusion. Haematocrit must be checked at the same intervals given the compound's pronounced erythropoietic effect; values approaching 54% warrant immediate dose reassessment. Lipid panels and blood pressure monitoring are recommended throughout the active cycle.

PCT: A structured recovery protocol is required following cessation to address endogenous testosterone suppression. A SERM-based approach — using Clomiphene Citrate or Tamoxifen Citrate — initiated within days of the final tablet is the accepted clinical standard. Liver enzyme normalisation must be confirmed via a post-cessation blood panel drawn at least four weeks after the last dose before any subsequent cycle is considered.

Frequently asked questions

What unique physiological benefits does Oxymetholone offer that single-pathway oral androgens cannot match?: Oxymetholone delivers benefits through two converging mechanisms simultaneously: androgen receptor-mediated nitrogen retention and a direct erythropoietic stimulus that elevates red-cell mass. This dual-axis effect means users gain both intramuscular volumisation and enhanced oxygen-carrying capacity within the same cycle window — an advantage that single-pathway oral androgens such as Oxandrolone or Stanozolol cannot replicate at any dose.
Why do experienced athletes consistently choose Oxymetholone over other oral anabolic compounds for rapid strength gains?: Experienced athletes select Oxymetholone because its onset of measurable volumisation and strength improvement is faster than most alternative oral androgens — typically apparent within seven to ten days of starting administration. The compound's combined erythropoietic and anabolic signalling creates a compounded performance benefit that narrower compounds achieve only partially, making it the reference choice when rapid and broad physiological response is the protocol objective.
What makes the benefits of Oxymetholone distinct from those of structurally similar DHT-derived oral steroids?: Although Oxymetholone belongs to the DHT-derived structural class, it produces an erythropoietic drive that other DHT-derived compounds — Masteron or Stanozolol, for example — do not generate. This makes its benefit profile categorically broader: users gain not only androgenic anabolic signalling but also meaningful red-cell mass expansion, a physiological advantage with direct implications for training endurance and recovery speed.
Is the 50mg tablet concentration the highest available in this Oxymetholone product group, and why does concentration matter for dosing accuracy?: Yes — 50 mg per tablet is the highest single-tablet concentration in this product group. Higher concentration per unit means a complete reference daily dose is delivered as a single analytically verified tablet, eliminating the API distribution inconsistencies introduced when lower-dose tablets are split. Each tablet's potency is confirmed by HPLC before batch release, so the 50 mg figure reflects an analytically established quantity, not a nominal label claim.
How does the 100-tablet pack format support structured Oxymetholone protocols without requiring mid-cycle restocking?: The 100-tablet pack provides enough supply depth to cover multi-phase protocols — including an induction period, a full-dose active phase, and a controlled exit window — without interruption. For users following structured cycle architecture, having a single pack that supports the entire planned duration removes the logistical risk of a supply gap mid-cycle, which could disrupt the intended androgenic stimulus profile. (2) angle_used

Manufacturer

Swiss Pharma's oral tablet portfolio represents a deliberate counterbalance to its injectable line — not an afterthought. Where the brand's injectable products are built around vial-level endotoxin architecture, the oral tablet range applies equivalent analytical rigour to a fundamentally different production challenge: ensuring API uniformity at the individual tablet level, not just across a liquid batch. For the Oxymetholone 50mg/tab format, this means per-tablet HPLC content assay is a release gate, not a spot-check. The ratio of oral products to injectable products in Swiss Pharma's current catalogue reflects a strategic commitment to athletes whose protocols combine both administration routes — a dual-format approach requiring that the oral component meets the same documentation standard as the injectable partner it typically accompanies.

Product details

Brand	Swiss Pharma
Active ingredient	oxymetholone
Also known as	Anadrol, Anapolon, Oxymetholone, Oxymetholonee, Swiss Pharma Anadrol
Strength	50 mg
Form	Tabletten
Pack size	100 pieces
Item number	ORA-OXYM-SWI-023

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Anapolon 50mg/tab 20 Tablets by Abdi Ibrahim

Lab Tested

Anapolon 50mg/tab 20 Tabletten by Abdi Ibrahim

Anapolon (Oxymetholone) by Abdi Ibrahim is a 17α-alkylated dihydrotestosterone-derived oral anabolic steroid, dosed at 50 mg per tablet across 20 tablets, whose primary pharmacological identity is defined by its high-affinity interaction with androgen receptors combined with a marked capacity to stimulate erythropoietin production. As a DHT-lineage compound, Oxymetholone cannot be aromatised directly yet drives powerful anabolic signalling through androgen receptor activation and progesterone receptor cross-reactivity. Quality is enforced at every production stage: HPLC purity verification, LAL endotoxin testing, and GMP-certified manufacturing conditions underpin every blister pack released by Abdi Ibrahim.

€20.00

Anapolon 50mg/tab 60 Tablets by Balkan Pharmaceuticals

HPLC Verified

Anapolon 50mg/tab 60 Tabletten by Balkan Pharmaceuticals

Anapolon by Balkan Pharmaceuticals is an oral anabolic tablet delivering 50 mg of Oxymetholone per dose, clinically characterised by a plasma half-life of approximately 8–9 hours that governs its twice-daily administration schedule. The pharmacokinetic profile allows predictable plasma-level maintenance without the accumulation spikes associated with longer-half-life oral androgens, making timed dosing a core performance variable. Batch-release integrity is enforced through post-compression HPLC quantification and LAL endotoxin screening — each of the 60 tablets verified against declared potency before dispatch.

€48.00

Pro-Anadrol 50mg/tab 50 Tablets by Beligas Pharmaceuticals

Pharma Grade

Pro-Anadrol 50mg/tab 50 Tabletten by Beligas Pharmaceuticals

Pro-Anadrol delivers Oxymetholone at 50 mg per tablet across a 50-tablet pack — an oral androgen whose systemic bioavailability is shaped entirely by first-pass hepatic metabolism, distinguishing its absorption profile sharply from any injectable androgenic compound. Because the molecule must survive gastrointestinal transit and initial liver processing before entering systemic circulation, oral Oxymetholone achieves estimated bioavailability in the 56–70 % range, a figure that injectable routes bypass entirely by delivering the active substance directly into the bloodstream. Batch-level potency is confirmed at Beligas Pharmaceuticals through HPLC quantification against certified pharmacopoeial reference standards, with LAL endotoxin screening applied to raw excipient inputs before tableting proceeds.

€60.00

OxyTrex 25mg/tab 100 Tablets by Concentrex Labs

Purity Tested

OxyTrex 25mg/tab 100 Tabletten by Concentrex Labs

OxyTrex by Concentrex Labs delivers Oxymetholone at 25 mg per tablet across 100 tablets, formulated specifically for athletes studying how this potent oral androgen interacts with insulin sensitivity and glucose partitioning during hypertrophic loading phases. Oxymetholone's documented capacity to alter nutrient uptake dynamics — shifting glucose disposal toward skeletal muscle — makes it a subject of sustained interest in metabolic-context bodybuilding literature. Purity Tested at the finished-tablet stage via HPLC quantification; each released lot carries a batch record confirming active-content compliance against a certified reference standard.

€60.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00